VEREECK, Lode

Email Alert RSS Feed

Profile

Full Name
VEREECK, Lode
Email
lode.vereeck@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 1-20 of 71 (Search time: 0.003 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
12017To Pay or Not to Pay? Evaluating the Belgian Law Against Vulture FundsSOURBRON, Leentje; VEREECK, LodeJournal ContributionA1
22017The determinants of defensive medicine practices in BelgiumVANDERSTEEGEN, Tom; MARNEFFE, Wim; CLEEMPUT, Irina; VANDIJCK, Dominique; VEREECK, LodeJournal ContributionA1
32017Zelffinanciering als bedrijfsmodel voor openbare diensten: Gevalstudie justitieSOURBRON, Leentje; VEREECK, Lode; BIELEN, SamanthaJournal ContributionA1
42017Finanzwissenschaftliche Analyse der Vollkostendeckung des österreichischen JustizsystemsSOURBRON, Leentje; VEREECK, LodeJournal ContributionA1
52016Do self-supporting judicial systems impede equal access to justice? Evidence from Austria.SOURBRON, Leentje; VEREECK, LodeConference MaterialC2
62016Het kadaster en de "unieke taks"VEREECK, Lode; SOURBRON, Leentje; MARNEFFE, WimBook SectionB2
72015An Empirical Analysis of Case Disposition Time in BelgiumBIELEN, Samantha; MARNEFFE, Wim; VEREECK, LodeJournal ContributionA1
82015Internalizing the external cost of passenger vehicles in FlandersROOSEN, Jorg; MARNEFFE, Wim; VEREECK, LodeConference MaterialC2
92015Transaction CostsMARNEFFE, Wim; BIELEN, Samantha; VEREECK, LodeBook SectionB2
102015Litigation decisionBIELEN, Samantha; MARNEFFE, Wim; VEREECK, LodeBook SectionB2
112014The impact of no-fault compensation on health care expenditures: An empirical study of OECD countriesVANDERSTEEGEN, Tom; MARNEFFE, Wim; CLEEMPUT, Irina; VEREECK, LodeConference MaterialC2
122014Cost-effectiveness of gemcitabine versus PEGylated liposomal doxorubicin for recurrent or progressive ovarian cancer: comparing chemotherapy with nanotherapyBOSETTI, Rita; Ferrandina, Gabriella; MARNEFFE, Wim; Scambia, Giovanni; VEREECK, LodeJournal ContributionA1
132014A cross-country analysis of the impact of regulatory quality on commercial case disposition time.MARNEFFE, Wim; BIELEN, Samantha; VEREECK, LodeConference MaterialC2
142014Administrative burdens and economic growth in EuropeMARNEFFE, Wim; POEL, Kevin; BIELEN, Samantha; VEREECK, LodeConference MaterialC2
152013Assessing the need for quality-adjusted cost–effectiveness studies of nanotechnological cancer therapiesBOSETTI, Rita; MARNEFFE, Wim; VEREECK, LodeJournal ContributionA1
162013Handboek Openbare financiënMARNEFFE, Wim; VEREECK, Lode; Matthijs, Herman; Naert, FrankBookB1
172013De impact van wetgevingskwaliteit op de gerechtelijke achterstandBIELEN, Samantha; MARNEFFE, Wim; OOMS, Anne; VEREECK, LodeJournal ContributionA1
182013Assessing the need of quality-adjusted cost-effectiveness studies of nanotechnological cancer therapiesBOSETTI, Rita; MARNEFFE, Wim; VEREECK, LodeConference MaterialC2
192013Regulatory delay and growth: a cross country analysisMARNEFFE, Wim; VAN AARLE, Bas; VEREECK, LodeJournal ContributionA1
202012Valuing the reduced risk of mortality and injuries: findings from a contingent valuation study in FlandersDE BRABANDER, Bram; MARNEFFE, Wim; VEREECK, LodeJournal ContributionA1
show all